Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PD-1 antibody

PDCD1 Reactivity: Mouse FACS, Func Host: Rat Monoclonal 1H10 unconjugated
Catalog No. ABIN6253467
  • Target See all PD-1 (PDCD1) Antibodies
    PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
    Reactivity
    • 132
    • 73
    • 25
    • 5
    • 3
    • 1
    Mouse
    Host
    • 76
    • 60
    • 23
    • 11
    • 9
    • 3
    • 2
    Rat
    Clonality
    • 125
    • 56
    • 2
    Monoclonal
    Conjugate
    • 93
    • 13
    • 10
    • 10
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This PD-1 antibody is un-conjugated
    Application
    • 119
    • 58
    • 45
    • 37
    • 36
    • 19
    • 13
    • 13
    • 13
    • 12
    • 9
    • 9
    • 8
    • 8
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Functional Studies (Func)
    Purpose
    anti-PD-1 (mouse), mAb (blocking) (1H10) (preservative free)
    Characteristics
    Monoclonal Antibody. Recognizes mouse PD-1 (CD279). Does not cross-react with human PD-1d. Isotype: Rat IgG2akappa. Clone: 1H10. Applications: FACS, FUNC (Blocking). Liquid. In PBS. CD279 (Programmed Cell Death Protein 1, PD-1) is a type I transmembrane protein belonging to the CD28/CTLA-4 family of immunoreceptors that mediate signals for regulating immune responses. Members of the CD28/CTLA-4 family have been shown to either promote T cell activation (CD28 and ICOS) or downregulate T cell activation (CTLA-4 and PD-1). CD279 is expressed on activated T cells, B cells, myeloid cells and on a subset of thymocytes. In vitro, ligation of CD279 inhibits TCR-mediated T cell proliferation and production of IL-1, IL-4, IL-10 and IFN-gamma. In addition, CD279 ligation also inhibits BCR mediated signaling. CD279 deficient mice have a defect in peripheral tolerance and spontaneously develop autoimmune diseases.
    Purity
    >95 % (SDS-PAGE)
    Endotoxin Level
    <0.01EU/μg purified protein (LAL test, Lonza).
    Immunogen
    Mouse PD-1 transfected cell line.
    Clone
    1H10
    Isotype
    IgG2a kappa
    Top Product
    Discover our top product PDCD1 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    Liquid. In PBS.
    Preservative
    Without preservative
    Handling Advice
    After opening, prepare aliquots and store at -20 °C. Avoid freeze/thaw cycles.
    Storage
    4 °C,-20 °C
    Storage Comment

    Short Term Storage: +4°C

    Long Term Storage: -20°C

    Use & Stability: Stable for at least 1 year after receipt when stored at -20°C.

  • Target
    PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
    Alternative Name
    PD-1 (PDCD1 Products)
    Synonyms
    CD279 antibody, PD-1 antibody, PD1 antibody, SLEB2 antibody, hPD-1 antibody, hPD-l antibody, Ly101 antibody, Pdc1 antibody, programmed cell death 1 antibody, PDCD1 antibody, Pdcd1 antibody
    Background

    Alternate Names/Synonyms: CD279, Programmed Cell Death Protein 1

    Product Description: CD279 (Programmed Cell Death Protein 1, PD-1) is a type I transmembrane protein belonging to the CD28/CTLA-4 family of immunoreceptors that mediate signals for regulating immune responses. Members of the CD28/CTLA-4 family have been shown to either promote T cell activation (CD28 and ICOS) or downregulate T cell activation (CTLA-4 and PD-1). CD279 is expressed on activated T cells, B cells, myeloid cells and on a subset of thymocytes. In vitro, ligation of CD279 inhibits TCR-mediated T cell proliferation and production of IL-1, IL-4, IL-10 and IFN-gamma. In addition, CD279 ligation also inhibits BCR mediated signaling. CD279 deficient mice have a defect in peripheral tolerance and spontaneously develop autoimmune diseases.

    NCBI Accession
    NP_005009
    Pathways
    Cancer Immune Checkpoints
You are here:
Support